- Home
- CIX vs CRDF Comparison
CIX vs CRDF Comparison
Compare CIX & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIX
- CRDF
- Stock Information
- Founded
- CIX 1993
- CRDF 1999
- Country
- CIX United States
- CRDF United States
- Employees
- CIX N/A
- CRDF N/A
- Industry
- CIX Industrial Machinery/Components
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CIX Consumer Discretionary
- CRDF Health Care
- Exchange
- CIX Nasdaq
- CRDF Nasdaq
- Market Cap
- CIX 296.3M
- CRDF 288.7M
- IPO Year
- CIX 1998
- CRDF N/A
- Fundamental
- Price
- CIX $25.19
- CRDF $4.75
- Analyst Decision
- CIX
- CRDF Strong Buy
- Analyst Count
- CIX 0
- CRDF 3
- Target Price
- CIX N/A
- CRDF $10.33
- AVG Volume (30 Days)
- CIX 6.6K
- CRDF 948.4K
- Earning Date
- CIX 03-03-2025
- CRDF 02-27-2025
- Dividend Yield
- CIX 4.74%
- CRDF N/A
- EPS Growth
- CIX N/A
- CRDF N/A
- EPS
- CIX 1.52
- CRDF N/A
- Revenue
- CIX $150,690,000.00
- CRDF $688,000.00
- Revenue This Year
- CIX N/A
- CRDF $25.03
- Revenue Next Year
- CIX N/A
- CRDF N/A
- P/E Ratio
- CIX $16.32
- CRDF N/A
- Revenue Growth
- CIX N/A
- CRDF 49.57
- 52 Week Low
- CIX $20.60
- CRDF $1.65
- 52 Week High
- CIX $39.91
- CRDF $6.42
- Technical
- Relative Strength Index (RSI)
- CIX 49.24
- CRDF 62.77
- Support Level
- CIX $24.65
- CRDF $4.12
- Resistance Level
- CIX $25.60
- CRDF $4.38
- Average True Range (ATR)
- CIX 0.80
- CRDF 0.38
- MACD
- CIX 0.16
- CRDF 0.04
- Stochastic Oscillator
- CIX 70.17
- CRDF 80.17
About CIX CompX International Inc.
Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's operating segment includes Security Products and Marine Components. The company generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Its geographical segments are the United States, Canada, Mexico, and others, of which the United States accounts for the vast majority of revenue.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").